TPT-260 Dihydrochloride is primarily utilized in the field of medical research, particularly in studies focused on oncology. It acts as an inhibitor targeting specific proteins involved in cancer cell proliferation. Researchers employ this compound to investigate its potential in halting the growth of tumors, especially in cases where conventional treatments have shown limited efficacy. Its application extends to preclinical trials, where it is assessed for its ability to enhance the effectiveness of existing cancer therapies. Additionally, TPT-260 Dihydrochloride is used in cellular assays to better understand the molecular pathways that drive cancer progression, aiding in the development of targeted therapeutic strategies.